PhoenixBio, Apr-Jun (1Q) Ordinary Profit Decreases by 20%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Aug 14, 2025 3:40 pm JST Earnings

6190 PhoenixBio Co.,Ltd. 【J-GAAP】

Earnings Report

PhoenixBio Co.,Ltd. <6190> [TSE Growth] announced its financial results after the market closed on August 14th (15:40). The consolidated ordinary profit for the first quarter of the fiscal year ending March 2026 (April to June) decreased 20.0% from the same period last year to 20 million yen. Progress toward the plan for the six months ending September (first half) of 77 million yen was 26.0%.

In the most recent three-month period, from April to June (1Q), the operating profit margin significantly improved from 1.1% in the same period last year to 5.8%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Jun, 2023	439	7	47	42	11.6	104.4	Aug 14, 2023	J-GAAP
Apr - Jun, 2024	449	5	25	23	5.8	ー	Aug 13, 2024	J-GAAP
Apr - Jun, 2025	400	23	20	19	4.7	26.0	Aug 14, 2025	J-GAAP
YoY	-10.9%	+360.0%	-20.0%	-17.4%	-17.6%

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2024	788	-98	-123	-124	-30.9	0	Nov 14, 2024	J-GAAP
Apr - Sep, 2025 Guidance	895	76	77	73	17.9	0	May 15, 2025	J-GAAP
YoY	+13.6%	－	－	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2024	1,715	11	43	26	7.0	0	May 15, 2024	J-GAAP
Mar, 2025	1,541	-142	-155	-448	-111.0	0	May 15, 2025	J-GAAP
Mar, 2026 Guidance	1,759	167	168	161	39.6	0	May 15, 2025	J-GAAP
YoY	+14.1%	－	－	－	－

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Apr - Jun, 2024	449	5	25	23	5.8	1.1	Aug 13, 2024	J-GAAP
Jul - Sep, 2024	339	-103	-148	-147	-36.6	-30.4	Nov 14, 2024	J-GAAP
Oct - Dec, 2024	355	-55	-23	-26	-6.5	-15.5	Feb 14, 2025	J-GAAP
Jan - Mar, 2025	398	11	-9	-298	-73.8	2.8	May 15, 2025	J-GAAP
Apr - Jun, 2025	400	23	20	19	4.7	5.8	Aug 14, 2025	J-GAAP
YoY	-10.9%	+360.0%	-20.0%	-17.4%	-17.6%